TY - JOUR
T1 - Cytokine Production by Mononuclear Cells from Patients with Familial Infantile Bilateral Striatal Necrosis
AU - Ganelin Cohen, Esther
AU - Bessler, Hanna
AU - Djaldetti, Meir
AU - Straussberg, Rachel
N1 - Publisher Copyright:
© 2018 S. Karger AG, Basel.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Prompted by findings suggesting immune instability in infantile bilateral striatal necrosis (IBSN), we evaluated levels of proinflammatory (tumor necrosis factor α, interleukin [IL]-1β, IL-6, interferon [IFN]γ) and anti-inflammatory (IL-10 and IL-1ra) cytokines produced by peripheral blood mononuclear cells (PBMC) from 6 children with IBSN and 11 age-matched controls. Compared to controls, non-stimulated PBMC from the IBSN group produced a significantly lower level of IL-1ra (by 38%; p < 0.001) and significantly lower levels of TNFα, IL-1β, and IFNγ (by 36% [p < 0.001], 25% [p = 0.06], and 32% [p < 0.02]) under PBMC stimulation. The severe cachexia manifesting shortly after IBSN onset may impair the immunological state, placing patients at risk of death from hyperpyrexia and sepsis.
AB - Prompted by findings suggesting immune instability in infantile bilateral striatal necrosis (IBSN), we evaluated levels of proinflammatory (tumor necrosis factor α, interleukin [IL]-1β, IL-6, interferon [IFN]γ) and anti-inflammatory (IL-10 and IL-1ra) cytokines produced by peripheral blood mononuclear cells (PBMC) from 6 children with IBSN and 11 age-matched controls. Compared to controls, non-stimulated PBMC from the IBSN group produced a significantly lower level of IL-1ra (by 38%; p < 0.001) and significantly lower levels of TNFα, IL-1β, and IFNγ (by 36% [p < 0.001], 25% [p = 0.06], and 32% [p < 0.02]) under PBMC stimulation. The severe cachexia manifesting shortly after IBSN onset may impair the immunological state, placing patients at risk of death from hyperpyrexia and sepsis.
KW - Cytokines
KW - Familial infantile bilateral striatal necrosis
KW - Immunology
KW - Mononuclear cells
KW - Striatal necrosis
UR - http://www.scopus.com/inward/record.url?scp=85043459642&partnerID=8YFLogxK
U2 - 10.1159/000486861
DO - 10.1159/000486861
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29510394
AN - SCOPUS:85043459642
SN - 1021-7401
VL - 24
SP - 276
EP - 281
JO - NeuroImmunoModulation
JF - NeuroImmunoModulation
IS - 4-5
ER -